Participants with adverse events: 1 or more serious adverse events regardless of type of storage of the vaccine Clinical or laboratory criteria · healthy older adults aged ≥ 60 years
Live zoster vaccine showed no clear difference in participants with adverse events: 1 or more serious adverse events… compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events · people aged 60 years and older living in the community
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people aged 60 years and older living in the community
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Specific adverse events: haemorrhage · cognitively healthy people in late life
Aspirin leads to higher adverse events (haemorrhage) compared with placebo (high certainty).
1 finding from 1 review
Intervention not reported
Adverse drug events · older people (aged 65 years or older) living in care homes
1 finding from 1 review
Serious adverse events · aged 18 years and older undergoing elective surgery at any surgical site
1 finding from 1 review
Serious adverse events · aged 18 years and older undergoing elective surgery at any surgical site
1 finding from 1 review
Adverse events: lymphoedema · women (18 years and older) diagnosed with stage IB2 cervical cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · healthcare workers
1 finding from 1 review
Adverse events · healthcare students, including students in training for health professions delivering direct medical care (e.g. medical students, nursing…
1 finding from 1 review
Adverse events · critically ill patients 18 years or older demanding mechanical ventilation within the first 72 hours (Page 2013) or anticipated needing…
1 finding from 1 review
Adverse events · Older adults with root caries in permanent (mature) teeth (mean age 75 years)
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
The review found no eligible studies for this question.
1 finding from 1 review
Incidence of adverse events within 30 days of surgery · aged 18 years and older undergoing elective surgery at any surgical site
1 finding from 1 review
Incidence of adverse events within 30 days of surgery · aged 18 years and older undergoing elective surgery at any surgical site
1 finding from 1 review
Adverse events · full‐term born older infants
1 finding from 1 review
Participants with at least some Side Effects · community‐dwelling older adults ≥ 65 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participants with adverse events ‐ death Clinical criteria · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine showed no clear difference in participants with adverse events ‐ deathClinical criteria compared with placebo (moderate certainty).
1 finding from 1 review
Participants with adverse events Clinical or laboratory criteria · healthy older adults aged ≥ 60 years
Live zoster vaccine probably leads to higher participants with adverse eventsClinical or laboratory criteria compared with placebo (moderate certainty).
1 finding from 1 review
Participants with adverse events ‐ any local symptom Clinical criteria · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine probably leads to higher participants with adverse events ‐ any local symptomClinical criteria compared with placebo (moderate certainty).
1 finding from 1 review